Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025

  • Three epilepsy posters to be presented in scientific sessions at the American Academy of Neurology meeting
  • Long-term 36-month data from the ongoing X-TOLE OLE study of azetukalner in focal onset seizures (FOS)
  • Exploratory analysis of efficacy of azetukalner in FOS seizure sub-types
  • Patient survey findings on mental health and comorbidity burdens of FOS

VANCOUVER, British Columbia and BOSTON, April 04, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced multiple presentations at the upcoming American Academy of Neurology Annual Meeting (AAN 2025), taking place April 5-9, 2025 in San Diego, CA. Three posters will be presented, including long-term data from the ongoing X-TOLE open-label extension (OLE) study of azetukalner in patients with focal onset seizures (FOS). The Company will also present an exploratory efficacy analysis of FOS seizure subtypes from the X-TOLE study, as well as patient survey findings about the mental health and comorbidity burdens of FOS.

“Building upon more than 700+ patient-years of data to date, we are excited to share our 36-month azetukalner data from our ongoing X-TOLE open-label extension study in FOS showing sustained monthly reduction in seizure frequency, impressive seizure freedom rates, and a consistent AE safety profile suggesting long-term efficacy and tolerability of azetukalner,” stated Dr. Christopher Kenney, Chief Medical Officer of Xenon. “We are also presenting an exploratory analysis from our X‑TOLE study showing reduced seizure frequency rate across four focal seizure subtypes. These promising data sets support our conviction that azetukalner may offer hope for people who continue to seek new efficacious and well-tolerated therapies to address the debilitating impacts of uncontrolled seizures.”

  • Poster 9‑001:
    Long-term Safety and Efficacy of Azetukalner, a Novel, Potent Kv7 Potassium Channel Opener in Adults With Focal Epilepsy: Update From the Ongoing 7-year Open-Label Extension of X-TOLE

    Presenter: Jacqueline A. French, MD, New York University Grossman School of Medicine and NYU Langone Health
    Session:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials
    Date/Time: April 8 from 8:00 am – 9:00 am PT
  • Poster 9-012:
    Efficacy of Azetukalner in Focal Onset Seizure (FOS) Subtypes: Results From the Double‑Blind, Placebo‑Controlled X‑TOLE Study

    Presenter: Constanza Luzon Rosenblut, MD, Xenon Pharmaceuticals
    Session:P8: Epilepsy/Clinical Neurophysiology (EEG): Anti-seizure Medications: Clinical Trials
    Date/Time: April 8 from 8:00 am – 9:00 am PT
  • Poster 9‑001:
    Is the Mental Health Burden of Epilepsy Under-Recognized in Patients Reporting Focal Onset Seizures? A Patient-Reported Outcomes Study

    Presenter: Joanne M. Wagner, PhD, Xenon Pharmaceuticals
    Session:P6: Epilepsy/Clinical Neurophysiology (EEG): Health Care Utilization and Disparities in Epilepsy
    Date/Time: April 7 from 11:45 am – 12:45 pm PT

Exhibit Hall

Xenon is hosting booth #1110 in the Exhibit Hall, which is scheduled to open at 11:30 am PT on Saturday, April 6 and close on Wednesday, April 9 at 4:00 pm PT.


About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. For more information, please visit www.xenon-pharma.com.


Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 and Canadian securities laws. These forward-looking statements are not based on historical fact, and include statements regarding the timing of and potential results from clinical trials; the potential efficacy, safety profile, future development plans in current and anticipated indications, addressable market, regulatory success and commercial potential of our and our partners’ product candidates; the efficacy of our clinical trial designs; our ability to successfully develop and achieve milestones in our azetukalner and other pipeline and development programs; and our ability to successfully develop and obtain regulatory approval of azetukalner and our other product candidates. These forward-looking statements are based on current assumptions that involve risks, uncertainties and other factors that may cause the actual results, events, or developments to be materially different from those expressed or implied by such forward-looking statements. These risks and uncertainties, many of which are beyond our control, include, but are not limited to: clinical trials may not demonstrate safety and efficacy of any of our or our collaborators’ product candidates; promising results from pre-clinical development activities or early clinical trial results may not be replicated in later clinical trials; our assumptions regarding our planned expenditures and sufficiency of our cash to fund operations may be incorrect; our ongoing discovery and pre-clinical efforts may not yield additional product candidates; any of our or our collaborators’ product candidates, including azetukalner, may fail in development, may not receive required regulatory approvals, or may be delayed to a point where they are not commercially viable; we may not achieve additional milestones in our proprietary or partnered programs; regulatory agencies may impose additional requirements or delay the initiation of clinical trials; the impact of market, industry, and regulatory conditions on clinical trial enrollment; the impact of competition; the impact of expanded product development and clinical activities on operating expenses; the impact of new or changing laws and regulations; as well as the other risks identified in our filings with the U.S. Securities and Exchange Commission and the securities commissions in British Columbia, Alberta, and Ontario. These forward-looking statements speak only as of the date hereof and we assume no obligation to update these forward-looking statements, and readers are cautioned not to place undue reliance on such forward-looking statements.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Contacts:

For Investors:

Chad Fugere
Vice President, Investor Relations
(857) 675-7275
[email protected]

For Media:

Colleen Alabiso
Senior Vice President, Corporate Affairs
(617) 671-9238
[email protected]



NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) — NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today the pricing of an underwritten registered public offering of 16,000,000 shares of its common stock at a price of $0.50 per share.

Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager for the offering.

All of the shares of common stock to be sold in the offering will be sold by the Company. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 2,400,000 shares of its common stock at the public offering price less the underwriting discount.

The gross proceeds to the Company from this offering, before deducting underwriting discounts and commissions and offering expenses, but excluding any exercise of the underwriter’s option to purchase additional shares, are expected to be $8,000,000. The Company intends to use the net proceeds from this offering for general working capital purposes. The offering is expected to close on or about April 7, 2025, subject to customary closing conditions.

The shares will be issued pursuant to a shelf registration statement on Form S-3 (File No. 333-279871) that was declared effective by the U.S. Securities and Exchange Commission (“SEC”), on August 16, 2024. A preliminary prospectus supplement and accompanying prospectus relating to the offering was filed with the SEC and is available on the SEC’s website at www.sec.gov. A final prospectus supplement will be filed with the SEC. Copies of the final prospectus supplement and accompanying prospectus relating to the offering, when available, may also be obtained by contacting Ladenburg Thalmann & Co. Inc., 640 Fifth Avenue, 4th Floor, New York, New York 10019, or by telephone at (212) 409-2000 or by email at [email protected].

This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. Any offer, if at all, will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.

###

Forward Looking Statements

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, any information contained in this press release may be a forward–looking statement that involve known and unknown risks and uncertainties. In some cases, you can identify forward–looking statements by the words “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “objective,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “target,” “seek,” “contemplate,” “continue” and “ongoing,” or the negative of these terms, or other comparable terminology intended to identify statements about the future. Forward–looking statements include statements related to the offering. Although the Company believes that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual future results may be materially different from what we expect due to factors largely outside our control, including risks and uncertainties related to market and other conditions, the satisfaction of customary closing conditions related to the public offering, the impact of general economic, industry or political conditions in the United States or internationally and those described under the heading “Risk Factors” in our filings with the SEC. These forward–looking statements speak only as of the date of this press release and the Company undertakes no obligation to revise or update any forward–looking statements for any reason, even if new information becomes available in the future.

Contact Information

Chris Donovan
MZ Group – MZ North America
(914) 352-5853
[email protected]



Radius Recycling Reports Second Quarter Fiscal 2025 Financial Results

Ferrous and Finished Steel Sales Volumes Up Year-Over-Year

Positive Operating and Free Cash Flow

Radius Board Declares Quarterly Dividend

PORTLAND, Ore., April 04, 2025 (GLOBE NEWSWIRE) — Radius Recycling, Inc. (NASDAQ: RDUS) (“Radius” or the “Company”) today reported results for the second quarter of fiscal 2025 ended February 28, 2025.

The Company reported a loss per share from continuing operations of $(1.15) and a net loss of $(33) million in the second quarter of fiscal 2025, compared to ($1.19) and ($34) million, respectively, in the prior year second quarter. Adjusted EBITDA was approximately break-even in the second quarter of fiscal 2025, compared to $3 million in the prior year second quarter. Adjusted loss per share from continuing operations was $(0.99) in the second quarter of fiscal 2025, compared to ($1.04) in the prior year second quarter.

On a year-over-year basis, operating performance in the second quarter of fiscal 2025 was slightly lower primarily due to lower global ferrous and finished steel prices, including as a result of the dampening effect from elevated levels of Chinese steel exports, partially offset by higher ferrous and finished steel sales volumes, stronger nonferrous demand, and benefits from productivity initiatives:

  • Ferrous average net selling prices were 14% lower year-over-year. This, together with tight scrap flows exacerbated by particularly challenging winter weather conditions, led to a compression in metal spreads compared to the prior year quarter. Domestic and export market conditions diverged in the latter part of the quarter, as domestic ferrous scrap prices increased sharply and mills began restocking. This surge supported margin expansion on domestic shipments, but also contributed to a temporary spread compression on export sales that had already been contracted for the quarter. The impact of average inventory accounting in the second quarter of fiscal 2025 was approximately neutral, compared to a benefit of approximately $2 per ferrous ton in the second quarter of fiscal 2024.
  • Ferrous sales volumes were 12% higher compared to the prior year quarter, primarily benefiting from a reduction in inventories due to timing of shipments.
  • Stronger nonferrous demand led to 10% higher average net selling prices. Nonferrous sales volumes were 1% lower year-over-year primarily due to timing of shipments.
  • The contribution from finished steel was lower year-over-year primarily due to a decline in average net selling prices of 9%, although finished steel prices began to rise in the latter part of the quarter. This was partially offset by 15% higher finished steel sales volumes year-over-year as demand in the Company’s Western markets remained healthy. The mill utilization rate was 88% in the second quarter of fiscal 2025, compared to 81% in the prior year’s second quarter.
  • The second quarter of fiscal 2025 reflected the full contribution from the Company’s productivity initiatives implemented over the past year, which were the main drivers of the 12% reduction in consolidated Selling, General, and Administrative (SG&A) costs compared to the prior year quarter. Results for the second quarter of fiscal 2025 also included a $3 million gain from the Company’s asset monetization program, while the prior year second quarter had included a $2 million gain from insurance recoveries.

In the second quarter of fiscal 2025, the Company generated positive operating cash flow of $20 million, including a benefit to working capital primarily associated with a reduction in inventories on timing of shipments, and free cash flow of $13 million. Total debt was $430 million at the end of the quarter, and debt, net of cash, was $424 million. Capital expenditures were $11 million in the quarter.

The effective tax rate for the second quarter of fiscal 2025 was a benefit of 11% on a pre-tax loss. While the Company continues to be in a valuation allowance position, the tax rate in the second quarter included a favorable true-up resulting primarily from a change in estimates of projected full year performance used in its annual effective tax rate method.

During the second quarter of fiscal 2025, the Company returned capital to shareholders through its 124th consecutive quarterly dividend.

Declaration of Quarterly Dividend

The Board of Directors declared a cash dividend of $0.1875 per common share, payable May 5, 2025 to shareholders of record on April 21, 2025. The Company has paid a dividend every quarter since going public in November 1993.

Merger Update

On March 13, 2025, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Toyota Tsusho America, Inc. (“TAI”) pursuant to which, on the terms and subject to the conditions set forth in the Merger Agreement, the Company would become a wholly owned subsidiary of TAI (the “Merger”). The Board of Directors of the Company has approved the Merger Agreement and the transactions contemplated thereby, including the Merger. Subject to the satisfaction of the closing conditions, the Company anticipates the Merger to close in the second half of calendar 2025.

Earnings Conference Call

As a result of the pending Merger with TAI, the Company will not be holding a second quarter earnings conference call or webcast.

About Radius Recycling, Inc.

Radius is a leading North American recycler of ferrous and nonferrous metals with 53 operating facilities across 25 states, Puerto Rico, and Western Canada. The Company sells its products to U.S. and export customers from its locations on both the East and West Coasts of the U.S., the Southeast, Hawaii, and Puerto Rico. Radius’ integrated operating platform also includes 50 stores operating across the U.S. and Western Canada under its Pick-N-Pull brand which sell serviceable used auto parts from salvaged vehicles and receive over 4 million annual retail visits. The Company’s electric arc furnace and rolling mill located in McMinnville, Oregon is vertically integrated with its Pacific Northwest metals recycling operations and produces rebar, wire rod, and other specialty products that are sold to customers primarily in the Western U.S. and Western Canada. Radius began operations in 1906 in Portland, Oregon, where it remains headquartered.

Summary Results                                
($ in millions, except per share and per ferrous ton amounts)                                
    Quarter       Six Months ended  
    2Q25     1Q25     2Q24       2025     2024  
Revenues   $ 643     $ 657     $ 621       $ 1,299     $ 1,294  
Gross margin (total revenues less cost of goods sold)   $ 27     $ 33     $ 40       $ 61     $ 80  
Selling, general and administrative expense   $ 55     $ 57     $ 62       $ 112     $ 125  
Net income (loss)   $ (33 )   $ (37 )   $ (34 )     $ (70 )   $ (52 )
Net income (loss) per ferrous ton(5)   $ (30 )   $ (33 )   $ (35 )     $ (32 )   $ (24 )
Diluted income (loss) per share from continuing
operations attributable to Radius shareholders
                               
Reported   $ (1.15 )   $ (1.30 )   $ (1.19 )     $ (2.45 )   $ (1.83 )
Adjusted(1)   $ (0.99 )   $ (1.33 )   $ (1.04 )     $ (2.32 )   $ (1.68 )
Adjusted EBITDA(1)   $     $     $ 3       $     $ 4  
Adjusted EBITDA per ferrous ton(1)(5)   $     $     $ 3       $     $ 2  
Cash flows from (used in) operating activities   $ 20     $ (2 )   $ (55 )     $ 18     $ (56 )
                                 
Ferrous sales volumes (LT, in thousands)(2)     1,094       1,106       980         2,200       2,132  
Avg. net ferrous sales prices ($/LT)(3)   $ 330     $ 338     $ 384       $ 334     $ 368  
Nonferrous sales volumes (pounds, in millions)(2) (4)     174       177       176         352       358  
Avg. nonferrous sales prices ($/pound)(3) (4)   $ 1.03     $ 1.02     $ 0.94       $ 1.02     $ 0.93  
Finished steel average net sales price ($/ST)(3)   $ 756     $ 775     $ 832       $ 765     $ 832  
Finished steel sales volumes (ST, in thousands)     131       125       114         256       243  
Rolling mill utilization (%)     88 %     81 %     81 %       84 %     88 %
                                           

LT = Long Ton, which is equivalent to 2,240 pounds
ST = Short Ton, which is equivalent to 2,000 pounds

(1)  See Non-GAAP Financial Measures for reconciliation to U.S. GAAP.
(2)  Ferrous and nonferrous volumes sold externally and delivered to our steel mill for finished steel production.
(3)  Price information is shown after netting the cost of freight incurred to deliver the product to the customer.
(4)  Nonferrous sales volumes and average nonferrous prices excludes platinum group metals (“PGMs”) in catalytic converters.
(5)  May not foot due to rounding.

RADIUS RECYCLING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
($ in thousands, except per share amounts)
(Unaudited)
 
    Three Months Ended     Six Months ended  
    February 28,
2025
    November 30,
2024
    February 29,
2024
    February 28,
2025
    February 29,
2024
 
Revenues   $ 642,508     $ 656,537     $ 621,059     $ 1,299,045     $ 1,293,956  
Cost of goods sold     615,011       623,132       580,996       1,238,143       1,214,416  
Selling, general and administrative expense     54,943       56,684       62,160       111,627       125,262  
(Income) from joint ventures     (188 )     (448 )     (30 )     (636 )     (703 )
Asset impairment charges           184       1,476       184       1,476  
Restructuring charges and other exit-related activities     1,422       1,897       3,175       3,319       3,210  
Operating income (loss)     (28,680 )     (24,912 )     (26,718 )     (53,592 )     (49,705 )
Interest expense     (8,771 )     (8,862 )     (5,803 )     (17,633 )     (10,613 )
Other income (expense), net     209       636       (263 )     845       (432 )
Income (loss) from continuing operations before
income taxes
    (37,242 )     (33,138 )     (32,784 )     (70,380 )     (60,750 )
Income tax (expense) benefit     4,277       (3,791 )     (1,195 )     486       8,975  
Income (loss) from continuing operations     (32,965 )     (36,929 )     (33,979 )     (69,894 )     (51,775 )
Income (loss) from discontinued operations, net of tax                 (31 )           (33 )
Net income (loss)     (32,965 )     (36,929 )     (34,010 )     (69,894 )     (51,808 )
Net (income) loss attributable to noncontrolling interests     (12 )     (244 )     31       (256 )     (135 )
Net income (loss) attributable to Radius shareholders   $ (32,977 )   $ (37,173 )   $ (33,979 )   $ (70,150 )   $ (51,943 )
                               
Net income (loss) per share attributable to Radius
shareholders:
                             
Basic:                              
Income (loss) per share from continuing operations   $ (1.15 )   $ (1.30 )   $ (1.19 )   $ (2.45 )   $ (1.83 )
Net income (loss) per share   $ (1.15 )   $ (1.30 )   $ (1.19 )   $ (2.45 )   $ (1.83 )
Diluted:                              
Income (loss) per share from continuing operations   $ (1.15 )   $ (1.30 )   $ (1.19 )   $ (2.45 )   $ (1.83 )
Net income (loss) per share   $ (1.15 )   $ (1.30 )   $ (1.19 )   $ (2.45 )   $ (1.83 )
Weighted average number of common shares:                              
Basic     28,684       28,573       28,454       28,628       28,337  
Diluted     28,684       28,573       28,454       28,628       28,337  
Dividends declared per common share   $ 0.1875     $ 0.1875     $ 0.1875     $ 0.3750     $ 0.3750  

 
RADIUS RECYCLING, INC.

SELECTED OPERATING STATISTICS
(Unaudited)
 
              YTD  
  1Q25     2Q25     2025  
Total ferrous volumes (LT, in thousands)(1)   1,106       1,094       2,200  
Total nonferrous volumes (pounds, in thousands)(1)(2)   177,255       174,323       351,578  
Ferrous selling prices ($/LT)(3)                
Domestic $ 331     $ 353     $ 343  
Foreign $ 340     $ 321     $ 330  
Average $ 338     $ 330     $ 334  
Ferrous sales volume (LT, in thousands)                
Domestic   477       468       945  
Foreign   629       626       1,255  
Total   1,106       1,094       2,200  
Nonferrous average price ($/pound)(2)(3) $ 1.02     $ 1.03     $ 1.02  
Cars purchased (in thousands)(4)   56       60       116  
Auto stores at period end   50       50       50  
Finished steel average sales price ($/ST)(3) $ 775     $ 756     $ 765  
Sales volume (ST, in thousands)                
Rebar   85       85       170  
Coiled products   39       45       84  
Merchant bar and other   1       1       2  
Finished steel products sold   125       131       256  
Rolling mill utilization(5)   81 %     88 %     84 %
                       

LT = Long Ton, which is equivalent to 2,240 pounds
ST = Short Ton, which is equivalent to 2,000 pounds

(1)  Ferrous and nonferrous volumes sold externally and delivered to our steel mill for finished steel production.
(2)  Excludes PGMs in catalytic converters.
(3)  Price information is shown after netting the cost of freight incurred to deliver the product to the customer.
(4)  Cars purchased by auto parts stores only.
(5)  Rolling mill utilization is based on effective annual production capacity under current conditions of 580 thousand tons of finished steel products.

RADIUS RECYCLING, INC.

SELECTED OPERATING STATISTICS
(Unaudited)
 
                            YTD  
    1Q24     2Q24     3Q24     4Q24     2024

(6)
 
Total ferrous volumes (LT, in thousands)(1)     1,152       980       1,112       1,249       4,493  
Total nonferrous volumes (pounds, in thousands)(1)(2)     181,728       176,477       183,230       206,743       748,178  
Ferrous selling prices ($/LT)(3)                              
Domestic   $ 342     $ 391     $ 341     $ 323     $ 349  
Foreign   $ 359     $ 381     $ 354     $ 356     $ 361  
Average   $ 354     $ 384     $ 350     $ 348     $ 358  
Ferrous sales volume (LT, in thousands)                              
Domestic     535       483       528       504       2,051  
Foreign     617       497       584       744       2,442  
Total(6)     1,152       980       1,112       1,249       4,493  
Nonferrous average price ($/pound)(2)(3)   $ 0.91     $ 0.94     $ 1.04     $ 1.08     $ 1.00  
Cars purchased (in thousands)(4)     64       67       64       63       258  
Auto stores at period end     50       50       50       50       50  
Finished steel average sales price ($/ST)(3)   $ 831     $ 832     $ 817     $ 795     $ 818  
Sales volume (ST, in thousands)                              
Rebar     94       83       83       96       357  
Coiled products     34       30       42       43       148  
Merchant bar and other     1       1       1       1       4  
Finished steel products sold     129       114       126       140       509  
Rolling mill utilization(5)     95 %     81 %     88 %     97 %     90 %
                                         

LT = Long Ton, which is equivalent to 2,240 pounds
ST = Short Ton, which is equivalent to 2,000 pounds

(1)  Ferrous and nonferrous volumes sold externally and delivered to our steel mill for finished steel production.
(2)  Excludes PGMs in catalytic converters.
(3)  Price information is shown after netting the cost of freight incurred to deliver the product to the customer.
(4)  Cars purchased by auto parts stores only.
(5)  Rolling mill utilization is based on effective annual production capacity under current conditions of 580 thousand tons of finished steel products.
(6)  May not foot due to rounding.

RADIUS RECYCLING, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS
($ in thousands)
(Unaudited)
 
    February 28, 2025     August 31, 2024  
Assets            
Current assets:            
Cash and cash equivalents   $ 5,437     $ 5,552  
Accounts receivable, net     216,365       258,157  
Inventories     281,757       293,932  
Other current assets     42,602       51,486  
Total current assets     546,161       609,127  
Property, plant and equipment, net     654,523       672,192  
Operating lease right-of-use assets     130,686       123,546  
Goodwill     13,105       13,105  
Other assets     113,708       115,799  
Total assets   $ 1,458,183     $ 1,533,769  
             
Liabilities and Equity            
Current liabilities:            
Short-term borrowings   $ 5,480     $ 5,688  
Accounts payable     193,063       202,498  
Environmental liabilities     12,706       13,232  
Operating lease liabilities     21,159       19,262  
Other current liabilities     69,661       75,890  
Total current liabilities     302,069       316,570  
Long-term debt, net of current maturities     424,424       409,082  
Environmental liabilities, net of current portion     52,172       52,417  
Operating lease liabilities, net of current maturities     110,799       104,246  
Other long-term liabilities     23,715       25,714  
Total liabilities     913,179       908,029  
             
Total Radius Recycling, Inc. shareholders’ equity     542,716       623,112  
Noncontrolling interests     2,288       2,628  
Total equity     545,004       625,740  
Total liabilities and equity   $ 1,458,183     $ 1,533,769  



Non-GAAP Financial Measures
This press release contains performance based on adjusted diluted earnings per share from continuing operations attributable to Radius shareholders, adjusted EBITDA, adjusted EBITDA per ferrous ton, and adjusted selling, general, and administrative expense, which are non-GAAP financial measures as defined under SEC rules. As required by SEC rules, the Company has provided a reconciliation of these measures for each period discussed to the most directly comparable U.S. GAAP measure. Management believes that providing these non-GAAP financial measures adds a meaningful presentation of our results from business operations excluding restructuring charges and other exit-related activities, charges for legacy environmental matters (net of recoveries), amortization of capitalized cloud computing implementation costs, asset impairment charges, business development costs not related to ongoing operations including pre-acquisition and merger expenses, and the income tax benefit allocated to these adjustments, items which are not related to underlying business operational performance, and improves the period-to-period comparability of our results from business operations. We believe that presenting debt, net of cash is useful to investors as a measure of our leverage, as cash and cash equivalents can be used, among other things, to repay indebtedness. We define free cash flow as cash flow from operating activities, net of capital expenditures and proceeds from sales of property, plant, and equipment. We believe free cash flow is useful to investors as a measure of liquidity. These non-GAAP financial measures should be considered in addition to, but not as a substitute for, the most directly comparable U.S. GAAP measures.

Reconciliation of adjusted diluted earnings (loss) per share from continuing operations attributable to Radius shareholders                
($ per share)   Three Months Ended       Six Months ended  
    2Q25     1Q25     2Q24       2025     2024  
As reported   $ (1.15 )   $ (1.30 )   $ (1.19 )     $ (2.45 )   $ (1.83 )
Restructuring charges and other exit-related activities, per share     0.05       0.07       0.11         0.12       0.11  
Charges (recoveries) for legacy environmental matters, net, per share(1)     (0.01 )     (0.07 )     0.01         (0.08 )     0.02  
Asset impairment charges, per share                 0.06               0.07  
Business development costs, per share     0.09                     0.09       0.01  
Income tax benefit allocated to adjustments, per share(3)     0.03       (0.03 )     (0.03 )             (0.06 )
Adjusted(4)   $ (0.99 )   $ (1.33 )   $ (1.04 )     $ (2.32 )   $ (1.68 )

Reconciliation of adjusted EBITDA and adjusted EBITDA per ferrous ton                                
($ in millions)   Three Months Ended       Six Months ended  
    2Q25     1Q25     2Q24       2025     2024  
Net income (loss)   $ (33 )   $ (37 )   $ (34 )     $ (70 )   $ (52 )
Plus interest expense     9       9       6         18       11  
Plus income tax expense (benefit)     (4 )     4       1               (9 )
Plus depreciation and amortization     24       24       24         48       48  
Plus business development costs     3                     3        
Plus restructuring charges and other exit-related activities     1       2       3         3       3  
Plus charges (recoveries) for legacy environmental matters, net(1)           (2 )             (2 )      
Plus amortization of cloud computing software costs(2)                         1        
Plus asset impairment charges                 1               2  
Adjusted EBITDA(4)   $     $     $ 3       $     $ 4  
                                 
Ferrous sales volume (LT, in thousands)     1,094       1,106       980         2,200       2,132  
Adjusted EBITDA per ferrous ton sold ($/LT)   $     $     $ 3       $     $ 2  

Reconciliation of Adjusted selling, general and administrative expense:                                
($ in millions)   Three Months Ended       Six Months ended  
    2Q25     1Q25     2Q24       2025     2024  
As reported   $ 55     $ 57     $ 62       $ 112     $ 125  
(Charges) recoveries for legacy environmental matters, net(1)           2               2        
Business development costs     (3 )                   (3 )      
Adjusted(4)   $ 53     $ 59     $ 62       $ 111     $ 125  

Reconciliation of debt, net of cash                  
($ in thousands)                  
    February 28,
2025
    November 30,
2024
    February 29,
2024
 
Short-term borrowings   $ 5,480     $ 5,573     $ 5,459  
Long-term debt, net of current maturities     424,424       439,872       368,119  
Total debt     429,904       445,445       373,578  
Less: cash and cash equivalents     5,437       15,223       13,562  
Total debt, net of cash   $ 424,467     $ 430,222     $ 360,016  

Reconciliation of Free Cash Flow (FCF) Three Months Ended  
($ in thousands) 2Q25  
Cash flow from operating activities $ 19,954  
Capital expenditures   (11,334 )
Proceeds from sales of property, plant, and equipment   4,273  
Free cash flow $ 12,893  
       

LT = Long Ton, which is equivalent to 2,240 pounds

(1)  Legal and environmental charges, net of recoveries, for legacy environmental matters including those related to the Portland Harbor Superfund site and to other legacy environmental loss contingencies.
(2)  Amortization of cloud computing software costs consists of expense recognized in cost of goods sold and selling, general, and administrative expense resulting from amortization of capitalized implementation costs for cloud computing IT systems. This expense is not included in depreciation and amortization.
(3)  Income tax allocated to the aggregate adjustments reconciling reported and adjusted diluted (loss) earnings per share from continuing operations attributable to Radius shareholders is determined based on a tax provision calculated with and without the adjustments.
(4)  May not foot due to rounding.



Forward-Looking Statements
Statements and information included in this press release by Radius Recycling, Inc. that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Except as noted herein or as the context may otherwise require, all references in this press release to “we,” “our,” “us,” “the Company,” “Radius Recycling,” and “Radius” refer to Radius Recycling, Inc. and its consolidated subsidiaries.

Forward-looking statements in this press release include statements regarding future events or our expectations, intentions, beliefs, and strategies regarding the future, which may include statements regarding our proposed Merger with TAI, a U.S. subsidiary of Toyota Tsusho Corporation; the impact of equipment upgrades, equipment failures, and facility damage on production, including timing of repairs and resumption of operations; the realization of insurance recoveries; the Company’s outlook, growth initiatives, or expected results or objectives, including pricing, margins, volumes, and profitability; completion of acquisitions and integration of acquired businesses; the progression and impact of investments in processing and manufacturing technology improvements and information technology systems; the impact of sanctions and tariffs, quotas, and other trade actions and import restrictions; the impacts of supply chain disruptions, inflation, and rising interest rates; liquidity positions; our ability to generate cash from continuing operations; trends, cyclicality, and changes in the markets we sell into; strategic direction or goals; targets; changes to manufacturing and production processes; the realization of deferred tax assets; planned capital expenditures; the cost of and the status of any agreements or actions related to our compliance with environmental and other laws; expected tax rates, deductions, and credits; the impact of pandemics, epidemics, or other public health emergencies; the impact of labor shortages or increased labor costs; obligations under our retirement plans; benefits, savings, or additional costs from business realignment, cost containment, and productivity improvement programs; the potential impact of adopting new accounting pronouncements; and the adequacy of accruals.

Forward-looking statements by their nature address matters that are, to different degrees, uncertain, and often contain words such as “outlook,” “target,” “aim,” “believes,” “expects,” “anticipates,” “intends,” “assumes,” “estimates,” “evaluates,” “may,” “will,” “should,” “could,” “opinions,” “forecasts,” “projects,” “plans,” “future,” “forward,” “potential,” “probable,” and similar expressions. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

We may make other forward-looking statements from time to time, including in reports filed with the Securities and Exchange Commission, press releases, presentations, and on public conference calls. All forward-looking statements we make are based on information available to us at the time the statements are made, and we assume no obligation to update any forward-looking statements, except as may be required by law. Our business is subject to the effects of changes in domestic and global economic conditions and a number of other risks and uncertainties that could cause actual results to differ materially from those included in, or implied by, such forward-looking statements. Some of these risks and uncertainties are discussed in “Item 1A. Risk Factors” of Part I of our most recent Annual Report on Form 10-K. and Part II of our most recent Quarterly Report on Form 10-Q. Examples of these risks include: the completion of the Merger is subject to various risks and uncertainties related to, among other things, its terms, timing, structure, benefits, costs and completion; the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the disruption of management’s attention from the Company’s ongoing business operations due to the Merger; the effect of the announcement of the Merger on the Company’s relationships with its customers, third-party suppliers, industrial vendors and other third parties, as well as its operating results and business generally; the potential difficulties in employee retention as a result of the Merger; the Merger Agreement may be terminated in circumstances that may require the Company to pay TAI a termination fee; the fact that, if the Merger is completed, shareholders will forgo the opportunity to realize the potential long-term value of the successful execution of the Company’s current strategy as an independent company; required approvals to complete the Merger by our shareholders and the receipt of certain regulatory approvals, to the extent required, and the timing and conditions for such approvals; the stock price of the Company may decline significantly if the merger is not completed; the possibility that TAI could, at a later date, engage in unspecified transactions, including restructuring efforts, special dividends or the sale of some or all of the Company’s assets to one or more purchasers, that could conceivably produce a higher aggregate value than that available to shareholders in the Merger; the inability to consummate the Merger within the anticipated time period, or at all, due to any reason, including the failure to satisfy the closing conditions to the Merger; potential environmental cleanup costs related to the Portland Harbor Superfund site or other locations; the impact of equipment upgrades, equipment failures, and facility damage on production; failure to realize or delays in realizing expected benefits from capital and other projects, including investments in processing and manufacturing technology improvements and information technology systems; the cyclicality and impact of general economic conditions; the impact of inflation and interest rate and foreign currency fluctuations; changing conditions in global markets including the impact of sanctions and tariffs, quotas, and other trade actions and import restrictions; increases in the relative value of the U.S. dollar; economic and geopolitical instability including as a result of military conflict; volatile supply and demand conditions affecting prices and volumes in the markets for raw materials and other inputs we purchase; significant decreases in recycled metal prices; imbalances in supply and demand conditions in the global steel industry; difficulties associated with acquisitions and integration of acquired businesses; supply chain disruptions; reliance on third-party shipping companies, including with respect to freight rates and the availability of transportation; restrictions on our business and financial covenants under the agreement governing our bank credit facilities; potential limitations on our ability to access capital resources and existing credit facilities; the impact of impairment of goodwill and assets other than goodwill; the impact of pandemics, epidemics, or other public health emergencies; inability to achieve or sustain the benefits from productivity, cost savings, and restructuring initiatives; inability to renew facility leases; customer fulfillment of their contractual obligations; the impact of consolidation in the steel industry; product liability claims; the impact of legal proceedings and legal compliance; the impact of climate change; the impact of not realizing deferred tax assets; the impact of tax increases and changes in tax rules; the impact of one or more cybersecurity incidents; the impact of increasing attention to environmental, social, and governance matters; translation risks associated with fluctuation in foreign exchange rates; the impact of hedging transactions; inability to obtain or renew business licenses and permits; environmental compliance costs and potential environmental liabilities; increased environmental regulations and enforcement; compliance with climate change and greenhouse gas emission laws and regulations; the impact of labor shortages or increased labor costs; reliance on employees subject to collective bargaining agreements; and the impact of the underfunded status of multiemployer plans in which we participate.

Company Contact:

Investor Relations:
Michael Bennett
(503) 323-2811
[email protected] 
 
Public Affairs & Communications:
Eric Potashner
www.radiusrecycling.com 
[email protected] 
 
Company Info:
www.radiusrecycling.com 
[email protected] 



SIMPPLE Ltd. Wins Second Contract, Worth $524,000, to Supply Autonomous Cleaning Robots at Singapore Airport Terminal

Singapore, April 04, 2025 (GLOBE NEWSWIRE) — SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced the Company has been awarded a follow-up contract, valued at $524,000, for the supply of autonomous cleaning robotics to Singapore’s international airport.

Today’s announcement follows the Company’s release on November 15, 2024, detailing the win of an initial $400,000 contract for the supply of autonomous cleaning robots at the same airport. Both contracts are the result of a bidding process as part of the airport’s renewal program with another remaining contract for three terminals left to be awarded.

“We are proud to have been awarded this prestigious supply and maintenance contract, while remaining committed in our promise to deliver innovative service solutions that contribute to maintaining Singapore’s highly regarded airport facility,” said SIMPPLE chief executive Norman Schroeder. “These contract wins further underpin the longstanding relationship we have as a trusted partner for the past 8 years.  With a proven track record in delivering cutting edge robotics and an unwavering commitment to customer service, I believe SIMPPLE will continue to deliver fit-for-purpose and up-to-date solutions well into the future. Following this latest announcement, I look forward to providing more updates in the very near future.”

About SIMPPLE LTD.

Headquartered in Singapore, SIMPPLE LTD. is an advanced technology solution provider in the emerging PropTech space, focused on helping facilities owners and managers manage facilities autonomously. Founded in 2016, the Company has a strong foothold in the Singapore facilities management market, serving over 60 clients in both the public and private sectors and extending out of Singapore into Australia and the Middle East. The Company has developed its proprietary SIMPPLE Ecosystem, to create an automated workforce management tool for building maintenance, surveillance and cleaning comprised of a mix of software and hardware solutions such as robotics (both cleaning and security) and Internet-of-Things (“IoT”) devices. 

For more information on SIMPPLE, please visit: https://www.simpple.ai

Safe Harbor Statement

This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

For investor and media queries, please contact:
SIMPPLE LTD.
Investor Relations Department
Email: [email protected]

Visit the Investor Relation Website: https://www.investor.simpple.ai/

Skyline Corporate Communications Group, LLC

Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Tel: (646) 893-5835
Email: [email protected]  



For investor and media queries, please contact:
SIMPPLE LTD.
Investor Relations Department
Email: [email protected]

SKYLINE CORPORATE COMMUNICATIONS GROUP, LLC
Scott Powell 
President
Email: [email protected]  

Arqit Quantum Inc. Announces Select Preliminary Financial Results for First Half of Fiscal Year 2025

LONDON, April 04, 2025 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (“Arqit”), a global leader in quantum-safe encryption, announces select preliminary financial results for the first half of fiscal year 2025.

Based on preliminary unaudited results, management expects the Company to report for the first half period ended 31 March 2025 revenue of approximately $18,000 to $67,000 and cash and cash equivalents of approximately $24.7 million as of 31 March 2025.

As previously announced, Arqit was awarded a multi-year enterprise license contract in the EMEA region for a government end user, which was signed prior to the end of the 2024 fiscal year. Revenue generation was expected to commence early in the first half of fiscal year 2025. However, due to end customer delay, revenue generation did not commence until late March, adversely affecting revenue for the period. The original terms of the contract remain in effect and represent a multi-year enterprise license that is expected to result in seven figures in annual recurring revenue in total.

The preliminary financial results discussed in this press release are based on management’s preliminary unaudited analysis of financial results for the first half of fiscal year 2025. As of the date of this press release, the Company has not completed its financial statement reporting and the Company’s independent accounting firm has not reviewed the preliminary financial data discussed in this press release. During the course of the Company’s half year closing procedures and independent accountant review process, including the finalization of its financial statements for and as of the period ended 31 March 2025, the Company may identify items that would require it to make adjustments, which may be material to the information presented above. As a result, the estimates above constitute forward-looking information and are subject to risks and uncertainties, including possible adjustments to preliminary results.

Arqit’s motion to dismiss the putative class action lawsuit in the United States District Court for the Eastern District of New York (Case No. 1:22-cv-02604) was denied at the pleading stage on 28 March 2025. The court’s decision does not reflect a view on the merits of the plaintiff’s claim. Arqit continues to believe that it has strong defenses to the underlying allegations and intends to vigorously defend this claim going forward on the merits.

Conference Call

The Company expects to report its complete first half results in May 2025 followed by a conference call. Additional details, including the date and time of the conference call, will be provided in advance of the event.

About Arqit

Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) supplies a unique encryption software service which makes the communications links of any networked device, cloud machine or data at rest secure against both current and future forms of attack on encryption – even from a quantum computer. Compatible with NSA CSfC Components and meeting the demands of NSA CSfC Symmetric Key Management Requirements Annexe 1.2. and RFC 8784, Arqit’s Symmetric Key Agreement Platform uses a lightweight software agent that allows end point devices to create encryption keys locally in partnership with any number of other devices. The keys are computationally secure and facilitate Zero Trust Network Access. It can create limitless volumes of keys with any group size and refresh rate and can regulate the secure entrance and exit of a device in a group. The agent is lightweight and will thus run on the smallest of end point devices. The product sits within a growing portfolio of granted patents. It also works in a standards compliant manner which does not oblige customers to make a disruptive rip and replace of their technology. In September 2024, Arqit was named as an IDC Innovator for Post-Quantum Cryptography, 2024. Arqit is winner of two GSMA Global Mobile Awards, The Best Mobile Security Solution and The CTO Choice Award for Outstanding Mobile Technology, at Mobile World Congress 2024, recognised for groundbreaking innovation at the 2023 Institution of Engineering and Technology Awards and winner of the National Cyber Awards’ Cyber Defence Product of the Year 2024 and Innovation in Cyber Award 2022, as well as the Cyber Security Awards’ Cyber Security Software Company of the Year Award 2022. Arqit is ISO 27001 Standard certified. www.arqit.uk

Media relations enquiries:

Arqit: [email protected]

Investor relations enquiries:

Arqit: [email protected]

Caution About Forward-Looking Statements

This communication includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These forward-looking statements are based on Arqit’s expectations and beliefs concerning future events and involve risks and uncertainties that may cause actual results to differ materially from current expectations. These factors are difficult to predict accurately and may be beyond Arqit’s control. Forward-looking statements in this communication or elsewhere speak only as of the date made. New uncertainties and risks arise from time to time, and it is impossible for Arqit to predict these events or how they may affect it. Except as required by law, Arqit does not have any duty to, and does not intend to, update or revise the forward-looking statements in this communication or elsewhere after the date this communication is issued. In light of these risks and uncertainties, investors should keep in mind that results, events or developments discussed in any forward-looking statement made in this communication may not occur. Uncertainties and risk factors that could affect Arqit’s future performance and cause results to differ from the forward-looking statements in this release include, but are not limited to: (i) the outcome of any legal proceedings that may be instituted against Arqit, (ii) the ability to maintain the listing of Arqit’s securities on a national securities exchange, (iii) changes in the competitive and regulated industries in which Arqit operates, variations in operating performance across competitors and changes in laws and regulations affecting Arqit’s business, (iv) the ability to implement business plans, forecasts, and other expectations, and identify and realise additional opportunities, (v) the potential inability of Arqit to successfully deliver its operational technology, (vi) the risk of interruption or failure of Arqit’s information technology and communications system, (vii) the enforceability of Arqit’s intellectual property, (viii) market and other conditions, and (ix) other risks and uncertainties set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in Arqit’s annual report on Form 20-F (the “Form 20-F”), filed with the U.S. Securities and Exchange Commission (the “SEC”) on 5 December 2024 and in subsequent filings with the SEC. While the list of factors discussed above and in the Form 20-F and other SEC filings are considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realisation of forward-looking statements.



Vimeo Announces ‘Vimeo Streaming’: a New Era of Video Monetization, Control, and Discovery on Every Screen

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) — (NASDAQ: VMEO) – Vimeo, the world’s most innovative video platform for creators and businesses, introduced the next era of content delivery and monetization with the launch of Vimeo Streaming. Any creator, big or small can launch their own streaming services and branded apps, and deliver a next-generation experience for their global audiences. With this release, Vimeo is offering more monetization choices, deeper analytics, more protection, and providing access to new multilingual AI-powered services.

Creators are looking to diversify their income streams, bypass ad-driven platforms, and engage directly with their audiences – enter Vimeo. In fact, by launching their own streaming services using Vimeo, creators have directly generated over $1 billion in the past three years.

Vimeo Streaming is an all-in-one platform that lets creators quickly launch their own branded streaming service, complete with custom apps – no coding experience required. As your audience grows, we grow with you. New subscription tiers and advanced analytics help you better understand and deliver the content your audiences love. To scale content globally, creators can use Vimeo’s other AI services to be fully multilingual alongside Vimeo’s new Digital Rights Management (DRM) services to provide advanced protection. For businesses seeking more flexibility and a custom experience, Vimeo offers APIs and an embeddable video player to integrate directly into the creator’s own service or website.

“Vimeo is proud to serve the professional creator. With our new Vimeo Streaming release, we are giving creators more ways to connect with and gain a deeper understanding of their audiences, more ways to monetize their content, and higher grade security,” said Philip Moyer, CEO of Vimeo. “Vimeo is also breaking down language barriers for creators with our new AI services. We believe creators should be in control of their work and how they are paid; so we’re taking the technologies that are usually only afforded by the biggest platforms and putting it in the hands of our customers, at a fraction of the cost.”

Vimeo Streaming is the next generation of Vimeo’s existing over-the-top (OTT) platform and is a technological leap forward for content and media businesses. The expense and technical difficulty of building, running, and scaling a streaming service independently can be daunting, along with the challenge of generating sustainable revenue and a connection with their audience. Vimeo Streaming streamlines this process and introduces exciting new features, including:

  • New video monetization and promotional tools:

    • Membership subscription tiering to offer new revenue opportunities and give your biggest fans special access to exclusive live events, merchandise, and more
    • Custom video bumpers to promote specific content or sponsorship campaigns
  • Enterprise-grade content protection to protect and help safeguard your work from unauthorized access or piracy
  • Advanced analytics to help understand your audience and get to know what they’re watching
  • AI-powered translations to quickly make and scale multilingual content with auto-captioning and audio dubbing for global accessibility

“Vimeo Streaming allows us to concentrate on our core competency—producing content—and leave the technical aspects to Vimeo,” said Sam Reich, CEO of Dropout, a successful comedy subscription streaming service from the creators of College Humor. “Our subscription business is far and away our biggest revenue driver, and Vimeo’s comprehensive suite of tools means we’re delivering it to our audience stylishly and reliably.”

Find out more at NAB 2025

To highlight the industry’s opportunities and educate users on Vimeo’s latest offerings in AI, streaming, and video technology, Vimeo will exhibit at the 2025 National Association of Broadcasters (NAB) Show in Las Vegas, April 6-9, 2025, in booth #W3613 within the LVCC West Hall.

In addition, Vimeo will moderate a customer fireside chat at the NAB Streaming Summit with the founders and producers of World of Wonder Entertainment, the company behind the Emmy-award-winning reality competition television series, “RuPaul’s Drag Race.” The session, Global Stage, Direct-to-Screen: World of Wonder’s Playbook for Fan-Powered Growth, will take place at 12 p.m. PT on April 8 in rooms W108-W109 within the LVCC West Hall.

To learn more about Vimeo Streaming, please visit www.vimeo.com/solutions/vimeo-streaming.

About Vimeo:

Vimeo (NASDAQ: VMEO) is the world’s most innovative video experience platform. We enable anyone to create high-quality video experiences to better connect and bring ideas to life. We proudly serve our community of millions of users – from creative storytellers to globally distributed teams at the world’s largest companies – whose videos receive billions of views each month. Learn more at www.vimeo.com.

Contact: Frank Filiatrault / [email protected]

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f9ad5077-46cf-462e-b953-b9610b60af32



Green Trade Joins SiteOne Landscape Supply

Green Trade Joins SiteOne Landscape Supply

ROSWELL, Ga.–(BUSINESS WIRE)–
SiteOne Landscape Supply, Inc. (NYSE: SITE) announced today its acquisition of Green Trade Nursery of Georgia (“Green Trade”), a wholesale distributor of nursery products with one location in Jasper, Georgia, north of Atlanta.

“We are very excited to welcome Green Trade to the SiteOne family. Pat and Dennis have built an outstanding reputation for delivering quality products and exceptional service to customers throughout the North Atlanta market. The addition of Green Trade extends our leading wholesale nursery presence in this growing market,” said Doug Black, Chairman and CEO of SiteOne Landscape Supply.

“The broad spectrum of products and industry experience at SiteOne will enable us to provide a wider range of solutions to meet our customers’ needs, while also providing greater opportunities for our associates,” said Dennis Simeone, co-owner of Green Trade.

“Green Trade was built with a dedication to creating strong relationships with our customers, employees and vendors. By joining the SiteOne team, we can create better opportunities for all our stakeholders,” said Pat Glisson, co-owner of Green Trade.

The addition of Green Trade marks the 100th acquisition for SiteOne since it became an independent company in 2013 and is the second in 2025 as the company continues to expand the number of markets in which it offers the full range of landscape products and services to landscape professionals.

About SiteOne Landscape Supply:

SiteOne Landscape Supply (NYSE: SITE), is the largest and only full product line national wholesale distributor of landscape supplies in the United States and has a growing presence in Canada. Its customers are primarily residential and commercial landscape professionals who specialize in the design, installation and maintenance of lawns, gardens, golf courses and other outdoor spaces. https://www.siteone.com/

Investor Relations:

SiteOne Landscape Supply, Inc.

470-270-7011

[email protected]

or

Media:

SiteOne Landscape Supply, Inc.

Erin Edstrom 404-395-5357

Vice President, Integrated Marketing

[email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Retail Other Retail Residential Building & Real Estate Commercial Building & Real Estate Construction & Property Landscape

MEDIA:

RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th

RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th

CEO Shaun Bagai to discuss the momentum of RenovoRx’s commercialization efforts for its RenovoCath® device, including an update on initial revenues generated, and continued progress on the ongoing Phase III TIGeR-PaC clinical trial

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath, a novel, FDA-cleared drug-delivery device, today announced that Chief Executive Officer Shaun Bagai will present at the LD Micro Invitational XV: New York 2025 conference taking place at the Westin Grand Central Hotel, New York, NY on April 10, 2025.

Mr. Bagai will discuss recent corporate milestones, including an update on RenovoRx’s continued momentum of its RenovoCath commercial efforts, including new purchase orders and reorders received from cancer center customers, and the realization of initial revenues from RenovoCath sales.

Mr. Bagai will also discuss progress on RenovoRx’s ongoing Phase III TIGeR-PaC clinical trial. TIGeR-PaC is evaluating RenovoRx’s lead drug-device combination product candidate (intra-arterial delivery of gemcitabine via the RenovoCath catheter, known as IAG) which uses the proprietary Trans-Arterial Micro-Perfusion (TAMP™) therapy platform for the treatment of locally advanced pancreatic cancer (LAPC). This combination product candidate, IAG, which is enabled by the FDA-cleared RenovoCath device, is currently under investigation and has not been approved for commercial sale.

Presentation Details:

Date: Thursday, April 10, 2025

Time: 3:30 p.m. ET

Webcast:https://ir.renovorx.com/news-events/ir-calendar-events

To schedule a one-on-one investor meeting with Mr. Bagai, please contact your LD Micro representative or KCSA Strategic Communications at [email protected].

About RenovoCath

Based on its FDA clearance, RenovoCath® is intended for the isolation of blood flow and delivery of fluids, including diagnostic and/or therapeutic agents, to selected sites in the peripheral vascular system. RenovoCath is also indicated for temporary vessel occlusion in applications including arteriography, preoperative occlusion, and chemotherapeutic drug infusion. For further information regarding our RenovoCath Instructions for Use (“IFU”), please see: IFU-10004-Rev.-F-Universal-IFU.pdf.

About the TIGeR-PaC Clinical Trial

TIGeR-PaC is an ongoing Phase III randomized multi-center study evaluating the proprietary TAMP™ (Trans-Arterial Micro-Perfusion) therapy platform for the treatment of LAPC. RenovoRx’s first investigational drug-device combination product candidate using the TAMP therapy platform enabled with the Company’s FDA-cleared RenovoCath® device for the intra-arterial administration of chemotherapy, gemcitabine (IAG).

About RenovoRx, Inc.

RenovoRx, Inc.(Nasdaq: RNXT) is a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, U.S. Food and Drug Administration (FDA)-cleared local drug delivery device, targeting high unmet medical needs. RenovoRx’s patented Trans-Arterial Micro-Perfusion (TAMP™) therapy platform is designed to ensure targeted therapeutic delivery across the arterial wall near the tumor site to bathe the target tumor, while potentially minimizing a therapy’s toxicities versus systemic intravenous therapy. RenovoRx’s novel approach to targeted treatment offers the potential for increased safety, tolerance, and improved efficacy, and its mission is to transform the lives of cancer patients by providing innovative solutions to enable targeted delivery of diagnostic and therapeutic agents.

In addition to the RenovoCath device, RenovoRx is also evaluating our novel Phase III drug-device combination oncology product candidate (intra-arterial gemcitabine, known as IAG). IAG is being evaluated under a U.S. investigational new drug application that is regulated by the FDA’s 21 CFR 312 pathway. The investigational IAG utilizes RenovoCath, the Company’s FDA-cleared drug-delivery device, indicated for temporary vessel occlusion in applications including arteriography, preoperative occlusion, and chemotherapeutic drug infusion. The combination of intra-arterial infusion of chemotherapy, gemcitabine, and the RenovoCath device is currently being evaluated for the treatment of LAPC by the Center for Drug Evaluation and Research (the drug division of FDA).

The combination product candidate, which is enabled the RenovoCath device, is currently under investigation and has not been approved for commercial sale. RenovoCath with gemcitabine received Orphan Drug Designation for pancreatic cancer and bile duct cancer, which provides 7 years of market exclusivity upon new drug application approval by the FDA.

RenovoRx is also engaged in implementing commercialization strategies utilizing its TAMP technology and FDA-cleared RenovoCath device as stand-alone device. In December 2024, RenovoRx announced the receipt of its first commercial purchase orders for RenovoCath devices. Additionally, certain of these customers have already initiated repeat orders as RenovoRx works to expand the number medical institutions that have initiated the process for RenovoCath purchase orders, including several esteemed, high volume National Cancer Institute-designated centers. To meet and satisfy the anticipated demand, RenovoRx will continue to actively explore further revenue-generating activity either on its own or in tandem with a medical device commercial partner.

For more information, visit www.renovorx.com. Follow RenovoRx on Facebook, LinkedIn, and X.

Cautionary Note Regarding Forward-Looking Statements

This press release, the conference presentation referred to herein, and statements of the Company’s management made in connection therewith contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, including but not limited to statements regarding (i) our pre-clinical and clinical trials and studies, including the overall timing and timing for additional interim data readouts and full patient enrollment for our ongoing TIGeR-PaC Phase III clinical trial study in LAPC, (ii) the potential of RenovoCath® or TAMP™ as standalone commercial products, our anticipated timing for and levels of revenue generation from RenovoCath sales, and our commercialization plans in general, (iii) the potential for our product candidates to treat or provide clinically meaningful outcomes for certain medical conditions or diseases and (iv) our efforts to explore commercialization strategies utilizing our TAMP technology. Statements that are not purely historical are forward-looking statements. The forward-looking statements contained herein are based upon our current expectations and beliefs regarding future events, many of which, by their nature, are inherently uncertain, outside of our control and involve assumptions that may never materialize or may prove to be incorrect. These may include estimates, projections and statements relating to our research and development plans, commercial plans, intellectual property development, clinical trials, our therapy platform, business plans, financing plans, objectives and expected operating results, which are based on current expectations and assumptions that are subject to significant known and unknown risks and uncertainties that may cause actual results to differ materially and adversely from those expressed or implied by these forward-looking statements. These statements may be identified using words such as “may,” “expects,” “plans,” “aims,” “anticipates,” “believes,” “forecasts,” “estimates,” “intends,” and “potential,” or the negative of these terms or other comparable terminology regarding RenovoRx’s expectations strategy, plans or intentions, although not all forward-looking statements contain these words. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, that could cause actual events to differ materially from those projected or indicated by such statements, including, among other things: (i) the risk that our execution of our commercial strategy for RenovoCath or our TAMP technology may not lead to viable or repeating revenue generating operations; (ii) circumstances which would adversely impact our ability to efficiently utilize our cash resources on hand or raise additional funding, (iii) the timing of the initiation, progress and potential results (including the results of interim analyses) of TIGeR-PaC and any other preclinical studies, clinical trials and our research programs; (iv) the possibility that interim results may not be predictive of the outcome of our clinical trials, which may not demonstrate sufficient safety and efficacy to support regulatory approval of our product candidate, (v) that the applicable regulatory authorities may disagree with our interpretation of the data; research and clinical development plans and timelines, and the regulatory process for our product candidates; (vi) future potential regulatory milestones for our product candidates, including those related to current and planned clinical studies; (vii) our ability to use and expand our therapy platform to build a pipeline of product candidates; (viii) our ability to advance product candidates into, and successfully complete, clinical trials; (ix) the timing or likelihood of regulatory filings and approvals; (x) our estimates of the number of patients who suffer from the diseases we are targeting and the number of patients that may enroll in our clinical trials; (xi) the commercialization potential of our product candidates, if approved; (xii) our ability and the potential to successfully manufacture and supply our product candidates for clinical trials and for commercial use, if approved; (xiii) future strategic arrangements and/or collaborations and the potential benefits of such arrangements; (xiv) our estimates regarding expenses, future revenue, capital requirements and needs for additional financing and our ability to obtain additional capital; (xv) the sufficiency of our existing cash and cash equivalents to fund our future operating expenses and capital expenditure requirements; (xvi) our ability to retain the continued service of our key personnel and to identify, and hire and retain additional qualified personnel; (xvii) the implementation of our strategic plans for our business and product candidates; (xviii) the scope of protection we are able to establish and maintain for intellectual property rights, including our therapy platform, product candidates and research programs; (xix) our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately; (xx) the pricing, coverage and reimbursement of our product candidates, if approved; and (xxi) developments relating to our competitors and our industry, including competing product candidates and therapies. Information regarding the foregoing and additional risks may be found in the section entitled “Risk Factors” in documents that we file from time to time with the Securities and Exchange Commission.

Forward-looking statements included herein are made as of the date hereof, and RenovoRx does not undertake any obligation to update publicly such forward-looking statements to reflect subsequent events or circumstances, except as required by law.

KCSA Strategic Communications

Valter Pinto or Jack Perkins

T:212-896-1254

[email protected]

KEYWORDS: United States North America California New York

INDUSTRY KEYWORDS: Oncology Health Medical Devices General Health Clinical Trials Pharmaceutical Biotechnology

MEDIA:

Logo
Logo

Alaska Airlines announces investment in Loft Dynamics and partnership to develop and deploy first Boeing 737 VR simulators

PR Newswire

In a first for global airlines, Alaska Airlines will lend expertise from its industry-leading training program to inform development of next generation simulators.
Loft enters fixed-wing market, bringing FAA- and EASA-qualified VR technology to commercial airline training.


SEATTLE and ZURICH
, April 4, 2025 /PRNewswire/ — Ushering in the next era of pilot training, Alaska Airlines has announced an investment in Loft Dynamics — an industry leader in virtual flight training and the developer of the only FAA- and EASA-qualified virtual reality (VR) helicopter flight simulator. The investment made through Alaska Star Ventures, Alaska’s corporate venture capital arm, will support development of the first hyper-realistic, full-motion Boeing 737 VR simulator, using extended reality (XR) technology and techniques, with the goal of enhancing Alaska’s pilot training program and informing future training solutions across the industry.

Alaska has a long history of pioneering aviation advancements, from launching the first online ticket sales to becoming the first airline to design and implement satellite-based approaches. Now, by investing in the development of full-motion VR simulators, Alaska is once again moving the industry forward,” said Fabi Riesen, founder and CEO at Loft Dynamics. “With aviation safety as a top priority and a global pilot shortage still looming, this partnership paves the way for airlines worldwide to train the next generation of exceptional pilots more efficiently and effectively than ever before.”

Traditional full-motion simulators have long been the gold standard for airline training, providing an essential and proven method for pilot instruction. However, their substantial footprint, high cost, and operational constraints limit scalability and accessibility. As airlines, operators, and regulators seek more flexible solutions, VR is emerging as a powerful and influential solution.

“Pilot training has significantly evolved over the past 30 years, from training solely in an aircraft to using full-flight simulators. With the potential of Loft’s hyper-realistic VR simulator, we could be transforming commercial pilot training as we know it today,” said Capt. Jeff Severns, managing director of flight operations training at Alaska Airlines. “These VR simulators could provide a fully immersive, high-fidelity, data-driven experience that replicates real-world flight scenarios — all in a device compact enough to fit in a standard office. This accessibility could allow pilots to train more frequently and refine their skills with greater efficiency. We are committed to offering the most advanced training solutions available, including VR, and look forward to being Loft’s first fixed-wing customer.”

Alaska is supporting Loft in the development of a Boeing 737 full-motion VR flight simulator with the financial investment and the expertise of its flight operations training department. As part of this partnership — and once the VR simulators are developed, built and approved — Alaska and Loft aim to install them at individual Alaska bases for pilot training. These state-of-the-art simulators will feature:

  • Six-degrees-of-freedom full-motion platform with improved pilot motion cueing that replicates real-world physics, force feedback from flight controls and all haptic sensations of the aircraft.
  • A 360-degree panoramic 3D view, providing correct visual cues inside and outside the aircraft.
  • Advanced full-body pose tracking, allowing pilots to see their hand and body movements in real-time within the VR environment.
  • Customizable training scenarios and environments, enabling pilots to practice any situation, condition, and maneuver safely and realistically.
  • Compact size, requiring 1/12th the space of legacy full-flight simulators, allowing for increased accessibility and flexibility.
  • Virtual demonstration mode, which lets instructors record immersive lessons — including visuals, audio and control inputs — for pilots to replay and learn from during future simulator sessions.
  • LoftSPATIAL app for Apple Vision Pro, which, when connected to the simulator, enables pilots to use spatial computing to train anytime, anywhere.

“Our investment in Loft Dynamics underscores our conviction in this technology, which enables hyper-realistic training of complex scenarios more effectively and more relevantly,” said Pasha Saleh, director of corporate development at Alaska Airlines. “Over time, this technology would enable us to bring critical training closer to the pilot base, reducing unnecessary travel and time while delivering industry-leading pilot training. It represents a paradigm shift and has the potential to dramatically enhance the quality of commercial pilot training.”

The eventual Boeing 737 VR simulator will be submitted to the Federal Aviation Administration (FAA) for approval — likely in the next few years. In the interim, Alaska and Loft plan to explore training enhancement opportunities for pilots that would function as a supplement to existing FAA-required training.

About Loft Dynamics

Loft Dynamics AG is the global leader in qualified virtual reality flight simulation training devices (FSTD). It is the only VR FSTD qualified by the FAA and EASA. Equipped with a 3D high-resolution panoramic view, dynamic six-degrees-of-freedom motion platform, and full-scale replica cockpit with a unique pose tracking system, our revolutionary VR simulators provide a more immersive, realistic, customizable, and safe training experience. By offering a training solution 10 times smaller and significantly more cost-effective than legacy simulators, we enhance training accessibility and scalability, empowering highly skilled pilots to meet global demand. We serve leading manufacturers, airlines, operators, schools, and organizations worldwide. Headquartered in Santa Monica, California, and Zurich, Switzerland, our team comprises passionate engineers, developers, and aviation experts. Learn more at LoftDynamics.com.

About Alaska Air Group

Alaska Airlines, Hawaiian Airlines and Horizon Air are subsidiaries of Alaska Air Group, with McGee Air Services a subsidiary of Alaska Airlines. With hubs in Seattle, Honolulu, Portland, Anchorage, Los Angeles, San Diego and San Francisco, we deliver remarkable care as we fly our guests to more than 140 destinations throughout North America, Latin America, Asia and the Pacific. Alaska is a member of the oneworld Alliance with Hawaiian scheduled to join in 2026. With oneworld and our additional global partners, guests can earn and redeem miles for travel to over 1,000 worldwide destinations. Guests can book travel at alaskaair.com and hawaiianairlines.com. Learn more about what’s happening at Alaska and Hawaiian. Alaska Air Group is traded on the New York Stock Exchange (NYSE) as “ALK.”

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alaska-airlines-announces-investment-in-loft-dynamics-and-partnership-to-develop-and-deploy-first-boeing-737-vr-simulators-302420608.html

SOURCE ALASKA AIRLINES

Regency Centers Invites You to Join Its First Quarter 2025 Earnings Conference Call

JACKSONVILLE, Fla., April 04, 2025 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its first quarter 2025 earnings results on Tuesday, April 29, 2025, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Wednesday, April 30, 2025, at 11:00 a.m. ET.


First Quarter 2025 Earnings Conference Call
Date: Wednesday, April 30, 2025
Time: 11:00 a.m. ET
Dial#: 877-407-0789 or 201-689-8562
Webcast: 1st Quarter 2025 Webcast Link
   


Replay

Webcast Archive: Investor Relations page under Webcasts & Presentations

About Regency Centers Corporation (NASDAQ: REG)

Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member. For more information, please visit RegencyCenters.com

This press release was published by a CLEAR® Verified individual.